Literature DB >> 22009939

Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice.

Jiansheng Huang1, Yuzhi Jia, Tao Fu, Navin Viswakarma, Liang Bai, M Sambasiva Rao, Yijun Zhu, Jayme Borensztajn, Janardan K Reddy.   

Abstract

Obesity, a major health concern, results from an imbalance between energy intake and expenditure. Leptin-deficient ob/ob mice are paradigmatic of obesity, resulting from excess energy intake and storage. Mice lacking acyl-CoA oxidase 1 (Acox1), the first enzyme of the peroxisomal fatty acid β-oxidation system, are characterized by increased energy expenditure and a lean body phenotype caused by sustained activation of peroxisome proliferator-activated receptor α (PPARα) by endogenous ligands in liver that remain unmetabolized in the absence of Acox1. We generated ob/ob mice deficient in Acox1 (Acox1(-/-)) to determine how the activation of PPARα by endogenous ligands might affect the obesity of ob/ob mice. In contrast to Acox1(-/-) (14.3±1.2 g at 6 mo) and the Acox1-deficient (ob/ob) double-mutant mice (23.8±4.6 g at 6 mo), the ob/ob mice are severely obese (54.3±3.2 g at 6 mo) and had significantly more (P<0.01) epididymal fat content. The resistance of Acox1(-/-)/ob/ob mice to obesity is due to increased PPARα-mediated up-regulation of genes involved in fatty acid oxidation in liver. Activation of PPARα in Acox1-deficient ob/ob mice also reduces serum glucose and insulin (P<0.05) and improves glucose tolerance and insulin sensitivity. Further, PPARα activation reduces hepatic steatosis and increases hepatocellular regenerative response in Acox1(-/-)/ob/ob mice at a more accelerated pace than in mice lacking only Acox1. However, Acox1(-/-)/ob/ob mice manifest hepatic endoplasmic reticulum (ER) stress and also develop hepatocellular carcinomas (8 of 8 mice) similar to those observed in Acox1(-/-) mice (10 of 10 mice), but unlike in ob/ob (0 of 14 mice) and OB/OB (0 of 6 mice) mice, suggesting that superimposed ER stress and PPARα activation contribute to carcinogenesis in a fatty liver. Finally, absence of Acox1 in ob/ob mice can impart resistance to high-fat diet (60% fat)-induced obesity, and their liver had significantly (P<0.01) more cell proliferation. These studies with Acox1(-/-)/ob/ob mice indicate that sustained activation of lipid-sensing nuclear receptor PPARα attenuates obesity and restores glucose homeostasis by ameliorating insulin resistance but increases the risk for liver cancer development, in part related to excess energy combustion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22009939      PMCID: PMC3290446          DOI: 10.1096/fj.11-194019

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  55 in total

Review 1.  PPARs and the complex journey to obesity.

Authors:  Ronald M Evans; Grant D Barish; Yong-Xu Wang
Journal:  Nat Med       Date:  2004-04       Impact factor: 53.440

2.  UCP-mediated energy depletion in skeletal muscle increases glucose transport despite lipid accumulation and mitochondrial dysfunction.

Authors:  Dong-Ho Han; Lorraine A Nolte; Jeong-Sun Ju; Trey Coleman; John O Holloszy; Clay F Semenkovich
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-11-12       Impact factor: 4.310

3.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.

Authors:  I Issemann; S Green
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

Review 4.  Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice.

Authors:  D L Coleman
Journal:  Diabetologia       Date:  1978-03       Impact factor: 10.122

5.  Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens.

Authors:  J K Reddy; D L Azarnoff; C E Hignite
Journal:  Nature       Date:  1980-01-24       Impact factor: 49.962

Review 6.  Obesity and hepatocellular carcinoma.

Authors:  Stephen H Caldwell; Deborah M Crespo; Hyon Scott Kang; Abdullah M S Al-Osaimi
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

7.  Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver.

Authors:  Yuzhi Jia; Chao Qi; Papreddy Kashireddi; Sailesh Surapureddi; Yi-Jun Zhu; M Sambasiva Rao; Derek Le Roith; Pierre Chambon; Frank J Gonzalez; Janardan K Reddy
Journal:  J Biol Chem       Date:  2004-03-29       Impact factor: 5.157

8.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

9.  Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators.

Authors:  J K Reddy; S K Goel; M R Nemali; J J Carrino; T G Laffler; M K Reddy; S J Sperbeck; T Osumi; T Hashimoto; N D Lalwani
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

10.  Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor.

Authors:  P Tontonoz; E Hu; B M Spiegelman
Journal:  Cell       Date:  1994-12-30       Impact factor: 41.582

View more
  44 in total

1.  A negative feedback loop between microRNA-378 and Nrf1 promotes the development of hepatosteatosis in mice treated with a high fat diet.

Authors:  Tianpeng Zhang; Xiaoling Zhao; Clifford J Steer; Guiqin Yan; Guisheng Song
Journal:  Metabolism       Date:  2018-04-03       Impact factor: 8.694

2.  Interstrain differences in the severity of liver injury induced by a choline- and folate-deficient diet in mice are associated with dysregulation of genes involved in lipid metabolism.

Authors:  Volodymyr Tryndyak; Aline de Conti; Tetyana Kobets; Kristy Kutanzi; Igor Koturbash; Tao Han; James C Fuscoe; John R Latendresse; Stepan Melnyk; Svitlana Shymonyak; Leonard Collins; Sharon A Ross; Ivan Rusyn; Frederick A Beland; Igor P Pogribny
Journal:  FASEB J       Date:  2012-08-07       Impact factor: 5.191

Review 3.  Mitochondrial protein acylation and intermediary metabolism: regulation by sirtuins and implications for metabolic disease.

Authors:  John C Newman; Wenjuan He; Eric Verdin
Journal:  J Biol Chem       Date:  2012-10-18       Impact factor: 5.157

4.  Specific Inhibition of Acyl-CoA Oxidase-1 by an Acetylenic Acid Improves Hepatic Lipid and Reactive Oxygen Species (ROS) Metabolism in Rats Fed a High Fat Diet.

Authors:  Jia Zeng; Senwen Deng; Yiping Wang; Ping Li; Lian Tang; Yefeng Pang
Journal:  J Biol Chem       Date:  2017-01-11       Impact factor: 5.157

Review 5.  Liver function and dysfunction - a unique window into the physiological reach of ER stress and the unfolded protein response.

Authors:  D Thomas Rutkowski
Journal:  FEBS J       Date:  2018-02-07       Impact factor: 5.542

6.  Protective effect of thymoquinone against high-fructose diet-induced metabolic syndrome in rats.

Authors:  Pankaj Prabhakar; K H Reeta; S K Maulik; A K Dinda; Y K Gupta
Journal:  Eur J Nutr       Date:  2014-10-28       Impact factor: 5.614

7.  Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease.

Authors:  Maria E Moreno-Fernandez; Daniel A Giles; Traci E Stankiewicz; Rachel Sheridan; Rebekah Karns; Monica Cappelletti; Kristin Lampe; Rajib Mukherjee; Christian Sina; Anthony Sallese; James P Bridges; Simon P Hogan; Bruce J Aronow; Kasper Hoebe; Senad Divanovic
Journal:  JCI Insight       Date:  2018-03-22

8.  Does bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor?

Authors:  Terry D Hinds; Samuel O Adeosun; Abdulhadi A Alamodi; David E Stec
Journal:  Med Hypotheses       Date:  2016-08-31       Impact factor: 1.538

9.  High-fat diet induces fibrosis in mice lacking CYP2A5 and PPARα: a new model for steatohepatitis-associated fibrosis.

Authors:  Xue Chen; George K Acquaah-Mensah; Krista L Denning; Jonathan M Peterson; Kesheng Wang; James Denvir; Feng Hong; Arthur I Cederbaum; Yongke Lu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-09-02       Impact factor: 4.052

10.  Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways.

Authors:  Haiyan Zhang; Wen-Jun Shen; Yuan Cortez; Fredric B Kraemer; Salman Azhar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-10-25       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.